Atlas Trials

Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast Cancer

Clinical trial NCT03151447 · UNKNOWN

Trial details

NCT number
NCT03151447
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2017-03-06
Primary completion
2018-03-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.